In one paragraphArticle in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
15 authors.
Caroline KubaczkaStem Cell and Regenerative Biology Program, Boston Children's Hospital, Boston, MA 02115, USA.ORCID 0000-0002-7783-6602 Netra KambliStem Cell and Regenerative Biology Program, Boston Children's Hospital, Boston, MA 02115, USA.ORCID 0009-0009-4954-1127 Roland WindischStem Cell and Regenerative Biology Program, Boston Children's Hospital, Boston, MA 02115, USA.ORCID 0000-0003-1294-5151 Kelly YuStem Cell and Regenerative Biology Program, Boston Children's Hospital, Boston, MA 02115, USA.
Yunliang ZhaoStem Cell and Regenerative Biology Program, Boston Children's Hospital, Boston, MA 02115, USA.
Sharon WuStem Cell and Regenerative Biology Program, Boston Children's Hospital, Boston, MA 02115, USA.
Katie FrenisStem Cell and Regenerative Biology Program, Boston Children's Hospital, Boston, MA 02115, USA.
Morgan T WalcheckStem Cell and Regenerative Biology Program, Boston Children's Hospital, Boston, MA 02115, USA.
Marcelo FalchettiStem Cell and Regenerative Biology Program, Boston Children's Hospital, Boston, MA 02115, USA.ORCID 0000-0002-9438-680X Mohamad NajiaStem Cell and Regenerative Biology Program, Boston Children's Hospital, Boston, MA 02115, USA.ORCID 0000-0002-2558-8846 Zachary C LeBlancStem Cell and Regenerative Biology Program, Boston Children's Hospital, Boston, MA 02115, USA.ORCID 0000-0002-1662-2846 Trista E NorthStem Cell and Regenerative Biology Program, Boston Children's Hospital, Boston, MA 02115, USA.ORCID 0000-0003-1249-563X R Grant RoweStem Cell and Regenerative Biology Program, Boston Children's Hospital, Boston, MA 02115, USA.
George Q DaleyStem Cell and Regenerative Biology Program, Boston Children's Hospital, Boston, MA 02115, USA.
Thorsten M SchlaegerStem Cell and Regenerative Biology Program, Boston Children's Hospital, Boston, MA 02115, USA.
Funding
Molecular Circuits in the Hematopoietic Stem Cell NicheRC2DK120535 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI COLLINS, JAMES J, DALEY, GEORGE Q · 2020 to 2024
$8.2MDevelopmental Activation of the Inflammasome Controls Hematopoietic Stem Cell ProductionR01HL154580 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI NORTH, TRISTA E. · 2020 to 2023
$2.2MControl of hematopoietic maturation by Lin28b/let-7R01DK134515 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI Robert Grant Rowe · 2022 to 2026
$1.8MNHLBI NIH HHS R01 HL154580NIDDK NIH HHS R01 DK134515NIDDK NIH HHS RC2 DK120535
6 · The paper itselfAbstract
Genetically engineered human induced pluripotent stem cells (hiPSCs) represent a promising platform for regenerative medicine and next-generation immunotherapies. While recent advances enable stroma-free differentiation of hiPSCs into mature CD3
Indexed as
Aryl hydrocarbon receptor (AHR)autoimmune diseasecancer immunotherapyCAR-T cellschemical screencytotoxic T cellsDOT1LGSKhematopoiesislymphoid developmentpluripotent stem cellsT cell differentiationWNT
Identifiers
PMID41959015
PMCPMC13060064
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390